Benchmark International

Benchmarks Exclusive Opportunities

  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
Primary
  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
  • Home
  • About Us
  • Blog
  • Contact Us
  • From the Chairman
  • Offices
  • Opportunities
  • Stats Dashboard
    • Listing Stats
    • Your Listings

International Pharmaceutical Contract Research Organization – BN000033899

International
1M-5M500K-2M Care, Health & Medical
Add Photos
TEASER
CLIENT CODE: BN000033899
REVENUE/TURNOVER: $3,087,000
EBITDA: $534,000
HEADQUARTERS: Canada
 
Interested? Contact Us
813-898-2350
pmanry@benchmarkintl.com
International Pharmaceutical Contract Research Organization – BN000033899

Paul Manry

interested in this opportunity?
Browse My Listings

The company is an international contract research organization (CRO). The company’s primary services include consultation for technology transfer and drug development and manufacturing.

Key Aspects

  • Operating in growth mode; revenues and adjusted EBITDA grew at a compound annual growth rate (CAGR) of 107.1% and 77.9% from FY 2018 to 2021, respectively
  • Adjusted EBITDA margins have averaged 18.3% from FY 2018 to 2021
  • Extensive expert resources combining unique processes and full technology integration
  • Client base located worldwide
  • Large database of proprietary drug development and manufacturing resources
  • In operation for over 15 years

Opportunities

  • Capitalize on the highly scalable and profitable resources and methodology that the company currently has in place
  • Expand customer base to include a greater amount of pharmaceutical companies
  • Capitalize on an existing revenue model to drive growth in a rapidly growing industry

Headquartered

  • British Columbia

Potential Markets

  • The company currently serves small and medium-sized pharmaceutical companies located around the world.

Real Estate

  • The company operates from a 3,000 sq. ft. facility leased from an unrelated third party. There is room to grow in the current location.

Shareholder Objectives

  • The company is owned by a single shareholder. He believes the company is in a position to expand and take advantage of growth opportunities in the industry. The shareholder is seeking to pursue different activities; however, he is willing to stay with the company under new ownership for a transition period.

You Might Also Like

    AMERICAS HQ

    4030 West Boy Scout Blvd. Suite 500
    Tampa, FL 33609
    +1 813 898 2350
    US@Benchmarkintl.com

    Europe HQ

    101 Park Dr., Milton Park
    Oxfordshire, OX14 4RY
    +44 (0)1865 410 050
    UK@Benchmarkintl.com

    AFRICA HQ

    Ground Floor, Runway 01, Airport Office Park
    Cape Town International Airport, Cape Town, 7525
    +27 21 300 2055
    Africa@Benchmarkintl.com

    Copyright Benchmark International © 2022-2023. All Rights Reserved
    • LinkedIn
    • Twitter
    • Instagram
    • Vimeo
    • YouTube

    Login

    Lost your password?